ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,258, issued on April 7, was assigned to THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.).

"Inhibitors of MHC-I Nef downmodulation for treating HIV" was invented by David H. Sherman (Ann Arbor, Mich.), Kathleen L. Collins (Ann Arbor, Mich.), Andrew W. Robertson (Ann Arbor, Mich.) and Mark M. Painter (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds that can inhibit MHC-I downmodulation, and treat HIV infection in a patient in need of treatment thereof."

The patent was filed on Dec. 16, 2020, under Application No. 17/785,809.

*For further information, including images, charts and tables, pleas...